Supply Chain Archives
04/22/2025
Advancing Standardization in Cell and Gene Therapy Supply Chains
The future of cell and gene therapy depends not only on scientific advancements but also on the efficiency and reliability of its supply chain. In a recent panel discussion at Advanced Therapies Congress in London, Mark Flower, VP of Business Development, Cryopreservation at Cryoport Systems, explored the critical need for standardization, the challenges in achieving it, and the opportunities to improve logistics, manufacturing, and delivery systems.
04/18/2025
Transforming Patient Access to CGT: Q&A with Aruna Mor
Aruna Mor, Chief Commercial Officer at Cryoport Systems, recently delivered a powerful keynote at Advanced Therapies Congress in London, shedding light on the complexities of patient access and the critical steps needed to overcome these barriers. We sat down with her to delve deeper into some of the key themes of her keynote, exploring the intersection of science, logistics, supply chain, regulation, and collaboration that will determine the future of Cell and Gene Therapy (CGT).
04/14/2025
Enabling the Outcome Through Enhancing Patient Accessibility
Cell and Gene Therapy (CGT) has emerged as one of the most transformative areas in modern medicine, shaping the future of healthcare and changing the face of next-generation therapeutic approaches. Yet, despite the continued scientific progress, a critical challenge persists in ensuring these therapies are accessible to the patients who need them most. This challenge was the focus of the keynote address at the Advanced Therapies Congress in London, delivered by Aruna Mor, Chief Commercial Officer at Cryoport Systems, where she spoke about to the state of patient access within the field of advanced therapeutics.
02/12/2025
Ensuring Patient Impact in Advanced Therapy Logistics: A Conversation with Cryoport Systems’ Experts
The logistics behind advanced therapies aren’t just about moving shipments from point A to point B, they’re about protecting the integrity of life-saving treatments and ensuring that patients receive them without compromise. Following their discussion at Advanced Therapies Week 2025, we sat down with Aruna Mor, Chief Commercial Officer, and Mike Dybicz, Senior Vice President & Chief Product Development Officer, to dive deeper into how Cryoport Systems prioritizes patient impact at every step of the supply chain.
02/06/2025
The Patient Ferris Wheel: Centering the Patient in the CGT Supply Chain
In a recent interview at ATW, Cryoport Systems' leadership discussed how securing the future of medicine starts with minimizing risk and maximizing patient impact. Their conversation, The Patient Ferris Wheel – Centering the Patient in CGT Supply Chain, explored how Cryoport Systems is driving innovation in shipping systems designed specifically for advanced therapies.
02/04/2025
Advancing Patient Outcomes Through Integrated Supply Chain Solutions
The landscape of advanced therapies is consistently shifting, requiring a seamless, high-quality supply chain to ensure the safe and effective delivery of life-saving treatments. In a recent interview at Advanced Therapies Week, Cryoport Systems leaders shared insights into how their integrated approach is shaping the future of supply chain management for the biopharmaceutical industry.
01/30/2025
Mapping the Future: Q&A with Mark Sawicki, Ph.D., on 2025 Trends in Cell and Gene Therapy
As the CGT industry enters a pivotal phase of commercial growth and therapy expansion, Cryoport Systems’ CEO, Mark Sawicki, Ph.D., shares his perspectives on where the market is headed.
01/13/2025
Top 10 Industry Predictions for 2025
Cryoport Systems’ CEO, Mark Sawicki, provides a comprehensive analysis into the challenges and growth opportunities shaping the CGT industry.
12/11/2024
